Digest Network Come funziona
Network
/
Società
Vi
Non verificato

Vifor International AG (CSL Vifor)

Di cosa scriviamo

Ecologia/Salute ambientaleFarmaceuticaFitnessSaluteSanità

5 comunicati stampa

Guarda tutti i comunicati
Press Release cover image
26/06/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
Fonte
Vifor International AG (CSL Vifor)
Emittente
PR News Wire
1.00
0
23/05/2025
Farmaceutica
Sanità
England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy
Fonte
Vifor International AG (CSL Vifor)
Emittente
PR News Wire
1.00
0
29/04/2025
Farmaceutica
Sanità
CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy
Fonte
Vifor International AG (CSL Vifor)
Emittente
PR News Wire
1.00
0
Press Release cover image
17/10/2024
Farmaceutica
Sanità
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
Fonte
Vifor International AG (CSL Vifor)
Emittente
PR News Wire
1.00
0
Press Release cover image
24/09/2024
Farmaceutica
Sanità
Biologia
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia
Fonte
Vifor International AG (CSL Vifor)
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0